It is well accepted that EPCs-mediated endothelium repair is beneficial for coronary heart disease, whereas abnormal angiogenesis is the hallmark of diabetic retinopathy and nephropathy and anti-VEGF agents have been applied for treating diabetic microvascular diseases. Here, VEGFA is linked to diabetic retinopathy.